WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 522457
Description: GNE-495 is a potent and selective MAP4K4 Inhibitor with efficacy in retinal angiogenesis. GNE-495 showed excellent potency and good PK and was used to demonstrate in vivo efficacy in a retinal angiogenesis model recapitulating effects that were observed in the inducible Map4k4 knockout mice. Mitogen-activated protein kinase kinase kinase kinase (MAP4K4, or HGK), and its homologues Misshapen and MIG-15 have been shown to regulate a multitude of biological processes, including embryonic development,metabolism, inflammation, neural regeneration, angiogenesis, and cancer.
MedKoo Cat#: 522457
Chemical Formula: C22H20FN5O2
Exact Mass: 405.1601
Molecular Weight: 405.43
Elemental Analysis: C, 65.18; H, 4.97; F, 4.69; N, 17.27; O, 7.89
Synonym: GNE-495; GNE 495; GNE495.
IUPAC/Chemical Name: 8-amino-N-(1-(cyclopropanecarbonyl)azetidin-3-yl)-2-(3-fluorophenyl)-1,7-naphthyridine-5-carboxamide
InChi Key: FYXCIBJXJYBWPX-UHFFFAOYSA-N
InChi Code: InChI=1S/C22H20FN5O2/c23-14-3-1-2-13(8-14)18-7-6-16-17(9-25-20(24)19(16)27-18)21(29)26-15-10-28(11-15)22(30)12-4-5-12/h1-3,6-9,12,15H,4-5,10-11H2,(H2,24,25)(H,26,29)
SMILES Code: O=C(C1=C2C=CC(C3=CC=CC(F)=C3)=NC2=C(N)N=C1)NC4CN(C(C5CC5)=O)C4
1. Ndubaku CO, Crawford TD, Chen H, et al. Structure-Based Design of GNE-495, a Potent and Selective MAP4K4 Inhibitor with Efficacy in Retinal Angiogenesis. ACS Med Chem Lett. 2015;6(8):913–918. Published 2015 Jun 29. doi:10.1021/acsmedchemlett.5b00174